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Summary
Background It has been suggested that maternal vitamin D status in pregnancy influences
the risk of asthma and atopy in the offspring. The epidemiological evidence to support
these claims is conflicting and may reflect chance findings and differences in how vitamin
D was assessed.
Objective To examine the association between blood total maternal 25-hydroxy vitamin D
(25(OH)D) concentrations in pregnancy and offspring asthma, atopy and lung function in
the largest birth cohort study to date.
Methods Participants were largely of white European origin and resident in the South
West of England. We examined the associations of maternal 25(OH)D concentrations in
pregnancy with the following outcomes in the offspring: wheeze, asthma, atopy, eczema,
hayfever, at mean age 7.5 years (n = 3652–4696 depending on outcome), IgE at 7 years
(n = 2915) and lung function and bronchial responsiveness at mean age 8.7 years
(n = 3728–3784).
Results Sixty-eight per cent of mothers had sufficient (> 50 nmol/L) concentrations of 25
(OH)D, 27% were insufficient (27.5–49.99 nmol/L) and 5% were deficient (< 27.5 nmol/L).
There was no evidence to suggest that maternal 25(OH)D concentration in pregnancy was
associated with any respiratory or atopic outcome in the offspring. These findings
remained after adjustment for season of measurement and for potential confounders.
There was also no evidence that these relationships followed a non-linear form and no
evidence that either deficient or high concentrations of maternal 25(OH)D were associated
with atopic or respiratory outcomes.
Conclusions We found no evidence that maternal blood 25(OH)D concentration in preg-
nancy is associated with childhood atopic or respiratory outcomes.
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Introduction
Vitamin D may play an important role in normal fetal
lung and immune system development [1] and there is
increasing speculation that maternal vitamin D status in
pregnancy might be causally linked to the development
of asthma and atopy in the offspring. It has been
argued that maternal vitamin D deficiency might, at
least in part, explain the rising prevalence of asthma
and allergic disease in some countries [2]. However, an
opposing argument holds that the increasing prevalence
of asthma and atopy may be partly a consequence of
the fortification of childhood foods with vitamin D and
hence high vitamin D status in early childhood [3–7].
Studies of maternal dietary intake have mostly
reported inverse relationships between maternal vitamin
D intake in pregnancy and early childhood wheeze,
asthma, allergic rhinitis and eczema [8–10]. However, a
major limitation of these studies is that diet makes a
relatively minor contribution to total vitamin D status,
which is derived largely from photosynthesis in the
skin. Hence, the value of analysing dietary vitamin D
intake alone as a means of effectively establishing the
influence of vitamin D on outcomes has been ques-
tioned as it leads to considerable misclassification of
total exposure. The gold standard measure of vitamin D
status is the blood concentration of 25-hydroxyvitamin
D (25(OH)D) [11]. Findings from studies using maternal
[5, 12, 13] or cord blood [14, 15] concentrations of 25
(OH)D have been conflicting. Three recent studies from
the United Kingdom, United States and Spain that
examined its association with childhood asthma were
null [12, 13, 15], though one reported a U-shaped asso-
ciation between cord blood 25(OH)D and IgE and aero-
allergens [15]. One study from New Zealand reported a
negative association with asthma [14], but another UK
study reported a positive association – a higher risk of
childhood asthma and wheeze among offspring born to
mothers with the highest 25(OH)D concentrations
(> 75 nmol/L) [5]. Factors such as residual confounding,
chance results attributable to small sample sizes and
differences in how vitamin D exposure and childhood
outcomes were measured (i.e. whether by dietary intake
estimation or blood concentrations), may explain some
of this between study heterogeneity.
Given these inconsistent findings, we have investi-
gated whether maternal 25(OH)D concentrations during
pregnancy are associated with atopic and respiratory
outcomes in the offspring in a large population-based
birth cohort study. Ours will be the largest and most
comprehensive (in terms of the range of related out-
comes assessed) study to date of these associations.
Materials and methods
Participants
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective population-based study that
recruited a cohort of 14 541 pregnancies resident in the
South West of England with expected dates of delivery
from 1st April 1991 to 31st December 1992 (http://
www.alspac.bris.ac.uk.) [16, 17]. A total 13 678 single-
ton live born infants resulted from these pregnancies.
Figure 1 shows the flow of participant through the
study to the eligible sample for this study. Only single-
ton live born offspring whose mother had a valid preg-
nancy 25(OH)D concentration and who had data on at
least one outcome were considered eligible (N = 5515).
Ethical approval for this study was obtained from the
ALSPAC Law and Ethics Committee and the Local
Research Ethics Committee.
Outcomes
When the children were 7.5 years old, the mothers were
asked: ‘Has your child had any of the following in the
past 12 months: wheezing; asthma; eczema; hayfever?’
Children were defined as having current doctor-diag-
nosed asthma (primary outcome of interest) if mothers
responded positively to the question: ‘Has a doctor ever
actually said that your study child has asthma?’ and
positively to one or both of the questions on wheezing
and asthma in the past 12 months. Forty-four per cent
of children fulfilling this definition of asthma demon-
strated bronchial hyperresponsiveness as defined by a
fall in forced expiratory volume in 1 s (FEV1) of 20%
or more following methacholine challenge up to and
including the maximum dose PD20 (1.2 mg) and 52%
were atopic.
Atopy at 7 years was defined as a positive reaction
(defined as a weal diameter ≥ 2 mm) to Dermatophago-
ides pteronyssinus, cat or grass (after subtracting saline
reactions from histamine and allergen weals and
excluding children unreactive to 1% histamine). Serum
total IgE was measured by fluoroimmunoassay using
the Pharmacia UNICAP system (Pharmacia & Upjohn
Diagnostics AB, Uppsala, Sweden).
Pulmonary function was measured at the 8-year
clinic at mean age 8.7 years (SD: 0.27) using a Vitalo-
graph 2120 electronic spirometer with a computer-
based on-screen incentive (Vitalograph, Maids Moreton,
UK). The tests adhered to American Thoracic Society
Recruited pregnancy cohort 
N = 14,541  
Of which 674 
excluded:  
69 unknown outcomes
604 no live birth
1 live birth only from a 
twin pregnancyIncluded pregnancy cohort
N = 13,867 
Further 250 excluded
189 Multiple pregnancies
61 died in first 12 monthsMother-offspring pairs with 
live, singleton infant 
surviving to 12 months
N = 13,617 5,903 with no 
pregnancy 25(OH)D 
excluded
N = 7,714 
Total mother-offspring pairs 
included in analysis: 5513
n of which had following outcomes: 
Wheeze: n = 4696
Asthma: n = 4648
Atopy: n = 3652
Eczema: n = 4686
Hayfever: n = 4673
IgE: n = 2915
FVC: n = 3784
FEV1: n = 3728
FEF25-75: n = 3784
BHR: n = 2409
Fig. 1. Flow chart of participants used in these analyses.
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criteria for standardization and reproducibility of flow-
volume measurement, with the exception of ATS rec-
ommendations for duration of expiration [18] as many
children did not fulfil the forced expiratory time > 6 s
end of test criteria, a minimal volume change over the
final second was used. Outcomes included FEV1, FVC,
FEF25–75 adjusted for gender, age and height and
expressed as standard deviation score (SDS). Following
baseline spirometry, children whose FEV1 was > 70%
predicted for height had a bronchial challenge test with
methacholine using the method of Yan et al. [19]. Dou-
bling doses of methcholine were administered at 1 min
intervals to a maximum cumulative dose of 1.2 mg and
expressed for each subject as the dose–response slope
of FEV1 (percentage decline from baseline). Bronchial
hyperresponsiveness (BHR) was defined as being in the
highest tertile of the dose–response slope.
Assessment of maternal and offspring 25(OH)
D concentrations
Maternal non-fasting blood samples taken as part of
routine antenatal care were collected and stored ini-
tially at 20°C and then at 80°C, with no further
freeze–thaw cycles to the time of 25(OH)D assessment.
Serum used to assess 25(OH)D could be from any stage
in pregnancy and hence we have participants with sam-
ples from the first, second or third trimester, and a
small number with repeat measurements of 25 (OH)D
concentration (4.8%). For those with a repeat sample,
we took the last available measure because the majority
of mothers had samples taken in the final trimester
(52%). The date of sampling was recorded and this was
used, together with the date of birth and gestational
age to determine gestational length at the time of 25
(OH)D assessment and also to adjust for seasonality of
measurement. Offspring serum 25(OH)D concentration
was assessed from samples obtained at mean age
9.8 years (standard deviation: SD 1.11). As detailed pre-
viously [20], 25(OH)D concentrations in both mothers
and offspring were measured in the same laboratory
using high-performance liquid chromatography–tandem
mass spectrometry with internal standard in a labora-
tory meeting the performance target set by the Vitamin
D External Quality Assessment Scheme Advisory Panel.
For these analyses, we use total 25(OH)D, further details
of this method are provided in the Online Repository.
Potential confounders and mediators
We considered the following as potential confounders
because of their known or potential plausible associa-
tion with both maternal concentrations of vitamin D
and with childhood atopic and lung function outcomes
[21, 22]: maternal factors during pregnancy [smoking,
infections, anxiety score, antibiotic use, paracetamol
use, body mass index (BMI) and alcohol intake], other
maternal factors (educational level, housing tenure,
financial difficulties, ethnicity, age, parity, history of
asthma, eczema, rhinoconjunctivitis, migraine) and
postnatal factors that may reflect a background socio-
economic confounding pathway originating prior to
birth (breastfeeding, day care, pets, exposure to damp/
mould in home, environmental tobacco smoke expo-
sure and number of younger siblings). The following
were considered as potential mediators of the relation-
ship of outcomes with maternal 25(OH)D: gestational
age, birth weight, head circumference, birth length,
BMI at age 7 years and offspring serum 25(OH)D. Gen-
der and offspring age was also adjusted for in all anal-
ysis because of their association with the outcomes in
this study. More details on how these covariables were
measured and classified are in Table S1 of the Online
Repository.
Statistical analysis
Derivation of 25(OH)D exposures. The main source of
25(OH)D3 [and hence total 25(OH)D] is synthesis in the
skin in response to UVB exposure, which means there is
a strong sinusoidal pattern of 25(OH)D with date of
blood collection (see Figure S1 in the Online Reposi-
tory). As bloods were sampled at random gestational
lengths during pregnancy, to make the measures more
comparable across mothers, we adjusted each woman’s
measure of 25(OH)D to the date corresponding to their
respective 3rd trimester midpoint (34 weeks) using a
sine–cosine regression model. We chose the 3rd trimes-
ter because the majority of mothers were sampled in
this trimester. This variable incorporates the seasonal
influence on 25(OH)D. To remove this seasonal influ-
ence in an attempt to obtain a marker of habitual vita-
min D concentrations for each mother, we used the
residuals from the sine–cosine regression model. Similar
trigonometric models were fitted in the offspring to
adjust for season as just described. More details on the
derivation of these variables are provided in the Online
Repository.
Main analyses. Logistic regression was used for binary
outcomes and linear regression for continuous out-
comes. IgE was log transformed to reduce positive
skewness. Three main sets of regression models were
considered: first a minimally adjusted model, adjusting
for maternal age and offspring sex; second a con-
founder-adjusted model, adjusting for socio-economic
variables, housing conditions, lifestyle behaviours,
illnesses during pregnancy, ethnicity, and several other
maternal characteristics; and third a model adjusting
for these confounders plus additional adjustment for
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the seasonal pattern of maternal 25(OH)D. This last
model was fitted in two steps, first the seasonal trend in
maternal 25(OH)D was removed (as explained above),
and this resulting variable was then used as the expo-
sure in regression models. Where we found a suggestive
association (suggestive in terms of a dose–response
trend across quintiles of exposure) with 25(OH)D and
an outcome, we fitted additional models with further
adjustment for potential mediators, first, adjusting for
gestational age and size at birth (birth weight, birth
length, head circumference) and size at 7 years (BMI),
and second, additionally adjusting for the offspring’s
seasonally adjusted 25(OH)D levels. Online Repository
Table S1 details the variables in each of these models.
Maternal 25(OH)D was modelled using quintiles to
allow us to explore non-linearity, as suggested by
others [15]. Wald tests were used to perform tests
of general association vs. the null hypothesis of no
association.
Additional analyses. To test whether associations were
driven by a threshold effect of greater risk in those
whose mothers had insufficient levels of vitamin D, we
examined associations of categories of 25(OH)D levels
(≥ 50 nmol/L; 27.5–49.99 nmol/L and < 27.5 nmol/L)
with outcomes, we also repeated analyses using
75 nmol/L as a higher threshold for sufficiency as rec-
ommended in a more recent review [23]. As a sensitiv-
ity analysis we also estimated the association between
maternal 25(OH) D and longitudinal wheeze phenotypes
from birth to 7 years. These phenotypes were extracted
using latent class models and distinguish between types
of wheeze based on persistence of symptoms [24] (see
Online Repository). Lastly, as airway development
occurs in the first trimester, we tested the interactions
between maternal 25(OH)D concentration and the tri-
mester of blood sample (categorized as a binary vari-
able indicating 1st trimester) in models of pulmonary
function. Here, each mother’s 25(OH)D concentration
was adjusted to the midpoint of their respective trimes-
ter of measurement (using the models described above).
If the effect of maternal 25(OH)D was stronger in the
first trimester, then this would provide some evidence
of a causal effect around a sensitive developmental per-
iod because we would expect maternal 25(OH)D to be
similarly confounded across trimesters.
Dealing with missing data. To increase efficiency and
minimize selection bias, we used multivariate multiple
imputation [25] to impute missing values of covariables
for eligible participants (see also Online Repository). We
also repeated analyses including only those with com-
plete data on all each outcome and covariables. Gener-
ally, the results were qualitatively similar, with slightly
larger standard errors and less power (see Figures S11
and S12 in the Online Repository where sample sizes
are also provided).
Results
Sample description and dataset
Of the 5513 maternal–offspring pairs included in this
study (Fig. 1) 1397 (25%), 1223 (22%) and 2893 (52%)
of the mothers had 25(OH)D assessed in the first, second
and third trimester, respectively, and 2884 (52%) of the
offspring were male. The majority of the mothers had
sufficient levels of 25(OH)D (≥ 50 nmol/L: 68%) and
only a small proportion were deficient (< 27.5 nmol/L:
5%) (Table 1 and Figure S3). Similarly, among offspring
at mean age 9 years, few had deficient (1.3%) or insuf-
ficient levels of 25(OH)D (21.0%). The prevalence of
reported wheeze and asthma in this cohort at 7 years
was approximately 10% (Table 1).
Table 1 compares the main outcomes and exposures
in the eligible sample included in the main analyses
presented here and in those who were excluded because
they did not have both an outcome measure and a mea-
sure of maternal 25(OH)D. Mothers of offspring with
missing outcome data tended to have lower concentra-
tions of 25(OH)D compared with those with available
data, while there was no difference in the prevalence of
any of the atopic outcomes between offspring of moth-
ers with an exposure measure and those without. Moth-
ers of offspring with missing data tended to be younger,
of higher parity, from non-white ethnic groups, more
likely to smoke and consume alcohol during pregnancy,
from lower socio-economic groups, have higher levels
of obesity, be less likely to be exposed to damp and
mould in the home, have higher exposure to antibiotics
and paracetamol during pregnancy and slightly lower
reports of eczema, rhinoconjunctivitis, cold and flu and
other infections. Eligible offspring with missing out-
come data were less likely to be born at term and on
average had a lower birth weight and a smaller head
circumference (results not shown).
Association between maternal 25(OH)D and covariables
Online Repository Table S2 shows the unadjusted asso-
ciations of maternal characteristics with their 25(OH)D
concentrations. Older and multiparous mothers had
higher 25(OH)D concentrations. Mothers who were
obese or underweight, exposed to tobacco smoke, and
of non-white ethnicity had lower mean 25(OH)D con-
centrations. Home ownership, higher education levels
and alcohol intake during pregnancy were associated
with higher 25(OH)D concentrations. Slightly higher
concentrations of 25(OH)D were seen among mothers
that took antibiotics during pregnancy while there was
© 2013 John Wiley & Sons Ltd, Clinical & Experimental Allergy, 43 : 1180–1188
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no evidence of an association between maternal atopic
history and 25(OH)D concentration. There was a modest
correlation between season adjusted serum concentra-
tions of 25(OH)D of pregnant mothers and those of their
offspring (r = 0.16) Seasonally adjusted maternal 25
(OH)D concentrations were strongly correlated with the
predicted third trimester concentrations that were not
adjusted for season (r = 0.88).
Maternal 25(OH)D and asthma and atopic outcomes
Figure 2 shows the associations of maternal 25(OH)D
with each of the asthma and atopic outcomes (these are
also tabulated in Online Repository Table S3). Maternal
25(OH)D was not associated with any of the asthma/
atopic outcomes. These null associations remained after
adjustment for potential confounders and for season of
measurement and there was no suggestion that off-
spring of mothers with very low (27.5 nmol/L) or high
levels of circulating 25(OH)D were at an altered risk for
atopic outcomes (see Figures S4 & S6 in Online Reposi-
tory). In analyses using the longitudinal wheeze pheno-
types, there was also little evidence to suggest any
association with maternal 25(OH)D even when compar-
ing persistent wheezers to infrequent or no wheezers
(see Figure S9 in Online Repository).
Maternal 25(OH)D and lung function
Figure 3 shows the associations of maternal 25(OH)D
with each of the lung function outcomes (these are also
tabulated in Online Repository Table S3). In unadjusted
models, there was a weak suggestion of a threshold
association between maternal 25(OH)D and FVC, FEV1
and BHR – offspring of mothers in the lowest quintile of
25(OH)D (< 38 nmol/L) tended to have poorer lung
function and a higher odds of BHR compared with those
from mothers in the higher quintiles. This pattern was
attenuated after adjusting for potential maternal con-
founders and in particular for seasonality and the poten-
tial mediating effect of offspring growth. Furthermore,
while this appeared to a be a qualitative dose–response
relationship, there was actually no statistical evidence to
support this overall relationship, and reanalysing 25(OH)
D as categories of deficient, insufficient and sufficient
[23] and using a threshold of 75 nmol/L also showed
null results for a test of overall association (see
Figures S5, S7 & S8 in online repository). As a post hoc
analysis to further examine the suggestive trends in
Fig. 3, we fitted equivalent models using age, height
and sex standardized lung function outcomes at
15 years and there was no evidence that the patterns
described above existed at this later age (see Figure S10
in Online Repository). There was a suggestion of an
overall association between seasonally adjusted mater-
nal 25(OH)D and FEV1 and FEF25-75 at 15 years
although the pattern across quintiles was inconsistent,
for example, compared with quintile 1, quintiles 2 and 4
had positive associations with FEV1 and FEF25-75,
whereas quintiles 3 and 5 showed no association.
Our tests of an interaction between trimester of
measurement and maternal 25(OH)D, did not provide
Table 1. Distributions of main outcomes and exposures among those included in analysis (observed data) and others available from the eligible
cohort (singletons surviving beyond 1 year, but who did not have both a maternal 25(OH)D measure and an outcome measure)
Included in analysis sample
(observed) Others from eligible cohort
P*N n (%) or median (IQR) N n (%) or median (IQR)
Serum 25(OH)D (nmol/L)†
Mother‡
< 27.5 257 (4.7%) 41 (6.4)
27.5 to 49.9 1489 (27.0%) 815 (32.3)
≥ 50 5513 3767 (68.3%) 2203 3018 (61.3) < 0.001
Median (IQR) 61.5 (46.0, 80.7) 57.7 (41.8, 77.6) < 0.001
Offspring atopic outcomes
Wheeze(~ 7.5 years) 4696 499 (10.6%) 3331 361 (10.8%) 0.8
Asthma (~ 7.5 years) 4648 576 (12.4%) 3290 393 (12.0%) 0.5
Eczema (~ 7.5 years) 4686 772 (16.5%) 3328 535 (16.1%) 0.6
Hayfever (~ 7.5 years) 4673 416 (8.9%) 3320 284 (8.6%) 0.6
Atopy (~ 7 years) 3652 784 (21.5%) 2703 583 (21.6%) 0.9
Serum IgE (~ 7 years) (ku/L) 2915 55.2 (18.5, 198) 2100 57.9 (20.3, 179) 0.39
*A test of the difference between those included in the analysis vs. others from the eligible cohort. v2 test for categorical variables and t-test of
log transformed variables for continuous variables.
†This n varies for each of our models because the n with each outcome is different and so here we report those with a maternal 25(OH) measure
and at least one recorded outcome vs. those without any of the outcome measures.
‡Adjusted for season.
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evidence that associations differed depending upon
which trimester of pregnancy 25(OH)D was assessed in
(P > 0.4 for all interaction tests).
Discussion
Summary of main findings
In the largest study to date to examine the association
of maternal 25(OH)D concentrations in pregnancy with
offspring asthma, atopy and lung function, we found
no evidence of a relationship between maternal 25(OH)
D concentration and childhood wheeze, asthma, atopy,
eczema, hayfever, IgE or pulmonary function, and no
suggestion that either high or low concentrations of
maternal 25(OH)D were associated with an increased
risk of these outcomes. These findings were consistent
regardless of adjustment for a range of potential con-
founding factors, including the seasonal influence on
25(OH)D.
Strengths and limitations
The main strengths of this study are the large sample
size, consideration of multiple atopic and respiratory
outcomes, control for multiple potential confounders,
incorporation of statistical methodology to account for
missing data, use of several derivations of the maternal
25(OH)D exposure to check the robustness and sensitiv-
ity of our findings and to check the nature (e.g. linear-
ity) of the association with each outcome.
Although we acknowledge the possibility of bias aris-
ing from loss to follow-up and missing data, we cannot
conceive of a mechanism by which the association of
maternal 25(OH)D and atopy or lung function would
differ in the incomplete cases. Furthermore, our imputa-
tion model was relatively comprehensive in terms of
the number of factors that predict the missing data and
so would give unbiased results under an assumption
that the data are missing at random. Serum 25(OH)D
was assessed at only one time-point during pregnancy,






















































































































Fig. 2. Minimally adjusted and adjusted odds ratios (OR) for offspring atopic outcomes comparing across quintiles of maternal 25(OH)D (min to
38 nmol/L (reference class); 38 to 52; 52 to 67; 67 to 89; 89 to max). For IgE the association is the mean% difference in IgE vs. the lowest (refer-
ence) quintile of maternal 25(OH)D. The P-values are a test of general association against the null of no effect. See Table S1 in the Online Reposi-
tory for a description of the covariables included in each model.
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this is unlikely to be representative of a mothers circu-
lating levels over the whole of pregnancy and may
have biased our results towards the null. Nonetheless,
this single time-point assessment is the same as in other
studies of this association and we would still have
expected to find evidence of an association, if one
existed, given the large sample size. Only a small pro-
portion of mothers and offspring had deficient levels of
25(OH)D and the majority of mothers had levels below
75 nmol/L, so it is possible that we were unable to
detect true associations operating at these levels. How-
ever, given the large sample size, and the range of vita-
min D values, we would have expected to see some
evidence of qualitative trends if this were the case and
none was present. Furthermore, from a public health
perspective maternal pregnancy vitamin D as a risk fac-
tor for future offspring atopy or respiratory health
would only be of major importance if it was relevant to
most of the population and not only those members at
the extremes. Although we used carefully constructed
models to derive each mother’s exposure to 25(OH)D,
these models were based on only one measure of 25
(OH)D per mother taken at a random date during preg-
nancy. It is possible that this is a poor marker of vita-
min D levels over pregnancy. However, we have
examined this exposure in several ways and find no
evidence that associations differ by trimester in which
25(OH)D was assessed and consistent null associations
were found for all methods of 25(OH)D assessment.
Serum 25(OH)D has been criticized as a proxy for vita-
min D associations. For instance, it has been suggested
that there is a need to distinguish between serum 25
(OH)D and effects of vitamin D supplementation, the
former being a prohormone representing a physiologi-
cal state that is only relevant at extremely high or low
levels, and the latter representing the non-physiological
action of interest [4]. Thus, the null findings here do
not necessarily preclude important effects from supple-
mentation, although trials have shown a positive and
strong association between supplementation and 25(OH)
D levels [26, 27].
Comparison with other studies
The null findings seen in our study agree well with a
recent analysis of maternal 25(OH)D measured in the
3rd trimester in a smaller UK cohort (Southampton
Women’s Study) which bears close resemblance to
ALSPAC in terms of population and geographic location
[13]. Likewise, similar null associations have been
reported from studies of maternal 25(OH)D and cord
blood 25(OH)D in the United States [15] and Spain [12].
Only one study reported a negative association with
cumulative wheeze to 5 years, but that study also found
no association with asthma [14]. We could find no
association with persistent wheeze to 6 years, even
when examining those with and without atopy (results
not shown). Although we could not directly investigate
the association of maternal 25(OH)D with early life
respiratory infections, the lack of association with tran-
sient early wheezing phenotype argues against a protec-
tive effect of prenatal vitamin D on respiratory viral































































































Fig. 3. Minimally adjusted and adjusted mean difference in pulmonary function outcomes at 8 years (SD units) between quintiles of maternal 25
(OH)D (min to 38 nmol/L (reference class); 38 to 52; 52 to 67; 67 to 89; 89 to max). The P-values are a test of general association against the null
of no effect. See Table S1 in the Online Repository for a description of the covariables included in each model.
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infections in early childhood. It is possible that the only
reported positive association of high maternal 25(OH)D
with a higher risk of asthma in a UK cohort was a
chance finding given the small sample size (< 500) [5].
The majority of positive findings come from studies
of maternal dietary intake of vitamin D in pregnancy
[8–10, 28]. However, given that vitamin D intake is a
poor proxy for total vitamin D status [11], apparent
associations with dietary vitamin D may have been
confounded by other dietary or non-dietary factors
which had not been controlled for in those birth cohort
studies. By way of analogy, in a study of vitamin D
and adult lung function we found that, whilst there
were apparent associations with dietary vitamin D
intake, there was no evidence for an association with
blood 25(OH)D concentrations [29]. Alternatively previ-
ous positive dietary findings may have arisen through
chance or represent publication bias. In support of this,
it is notable that analysis of the association of maternal
dietary vitamin D with offspring asthma, wheeze and
atopy in both the Southampton Women’s Survey [13]
and ALSPAC [30] failed to demonstrate an association.
Although animal studies have shown that vitamin D
is involved in normal fetal lung development [31], our
study is in general agreement with other epidemiologi-
cal studies that have considered later offspring lung
function in the general population – two studies have
reported null associations of maternal 25(OH)D [13, 32]
or dietary vitamin D intake [32] with offspring lung
function.
Conclusion and implications
Our results, from the largest study to date, suggest the
absence of a clinically important association between
maternal 25(OH)D and offspring respiratory health or
atopy. In particular, we have not found evidence to
suggest that higher prenatal vitamin D status in preg-
nancy protects against the development of early child-
hood wheezing or later asthma. Whilst definitive
evidence will only come from randomized trials of vita-
min D supplementation during pregnancy, which are
currently underway (e.g. see ISRCTN68645785) our
results suggest that these interventions are unlikely to
be beneficial for these outcomes. Reassuringly, our data
also suggest that higher maternal vitamin D status in
pregnancy is unlikely to increase the risk of atopy in
the offspring.
Acknowledgements
We are extremely grateful to all of the families who
took part in this study, the midwives for recruiting
them, and the whole ALSPAC team, which includes
interviewers, computer and laboratory technicians, cler-
ical workers, research scientists, volunteers, managers,
receptionists and nurses.
Conflicts of interest
The authors declare no conflicts of interest.
References
1 Goldring S, Warner O, Shaheen O,
Boyle J. Early life vitamin D status and
lung development. Curr Respir Med
Rev 2011; 7:396–403.
2 Litonjua AA, Weiss ST. Is vitamin D
deficiency to blame for the asthma
epidemic? J Allergy Clin Immunol
2007; 120:1031–5.
3 Wjst M. The vitamin D slant on
allergy. Pediatr Allergy Immunol 2006;
17:477–83.
4 Wjst M. Is vitamin D supplementation
responsible for the allergy pandemic?
Curr Opin Allergy Clin Immunol 2012;
12:257–62.
5 Gale CR, Robinson SM, Harvey NC
et al. Maternal vitamin D status during
pregnancy and child outcomes. Eur
J Clin Nutr 2008; 62:68–77.
6 Hypponen E, Sovio U, Wjst M et al.
Infant vitamin d supplementation and
allergic conditions in adulthood:
northern Finland birth cohort 1966.
Ann N Y Acad Sci 2004; 1037:
84–95.
7 Wjst M, Hypponen E. Vitamin D serum
levels and allergic rhinitis. Allergy
2007; 62:1085–6.
8 Camargo CA Jr, Rifas-Shiman SL,
Litonjua AA et al. Maternal intake of
vitamin D during pregnancy and risk
of recurrent wheeze in children at 3 y
of age. Am J Clin Nutr 2007; 85:788–
95.
9 Devereux G, Litonjua AA, Turner SW
et al. Maternal vitamin D intake dur-
ing pregnancy and early childhood
wheezing. Am J Clin Nutr 2007;
85:853–9.
10 Miyake Y, Sasaki S, Tanaka K, Hirota
Y. Dairy food, calcium and vitamin D
intake in pregnancy, and wheeze and
eczema in infants. Eur Respir J 2010;
35:1228–34.
11 Millen AE, Bodnar LM. Vitamin D
assessment in population-based stud-
ies: a review of the issues. Am J Clin
Nutr 2008; 87:1102S–5S.
12 Morales E, Romieu I, Guerra S et al.
Maternal vitamin D status in preg-
nancy and risk of lower respiratory
tract infections, wheezing, and asthma
in offspring. Epidemiology 2012;
23:64–71.
13 Pike KC, Inskip HM, Robinson S et al.
Maternal late-pregnancy serum 25-
hydroxyvitamin D in relation to child-
hood wheeze and atopic outcomes.
Thorax 2012; 67:950–6.
14 Camargo CA Jr, Ingham T, Wickens K
et al. Cord-blood 25-hydroxyvitamin
D levels and risk of respiratory infec-
tion, wheezing, and asthma. Pediatrics
2011; 127:e180–7.
15 Rothers J, Wright AL, Stern DA,
Halonen M, Camargo CA Jr. Cord
blood 25-hydroxyvitamin D levels are
associated with aeroallergen sensitiza-
tion in children from Tucson, Arizona.
J Allergy Clin Immunol 2011;
128:1093–9.
16 Boyd A, Golding J, Macleod J et al.
Cohort Profile: the ‘children of the
© 2013 John Wiley & Sons Ltd, Clinical & Experimental Allergy, 43 : 1180–1188
Pregnancy vitamin D and offspring atopy 1187
90s’–the index offspring of the Avon
Longitudinal Study of Parents and
Children. Int J Epidemiol 2012;
42:111–27.
17 Fraser A, Macdonald-Wallis C, Tilling
K et al. Cohort Profile: the Avon Lon-
gitudinal Study of Parents and Chil-
dren: ALSPAC mothers cohort. Int J
Epidemiol 2012; 42:92–7.
18 Arets HGM, Brackel HJL, van der Ent
CK. Forced expiratory manoeuvres in
children: do they meet ATS and ERS
criteria for spirometry? Eur Respir J
2001; 18:655–60.
19 Yan K, Salome C, Woolcock AJ. Rapid
method for measurement of bronchial
responsiveness. Thorax 1983; 38:760–
5.
20 Tolppanen AM, Sayers A, Fraser WD,
Lawlor DA. Association of serum
25-hydroxyvitamin D3 and D2 with
academic performance in childhood:
findings from a prospective birth
cohort. J Epidemiol Community Health
2012; 66:1137–42.
21 Shaheen SO, Newson RB, Henderson
AJ et al. Prenatal paracetamol expo-
sure and risk of asthma and elevated
immunoglobulin E in childhood. Clin
Exp Allergy 2005; 35:18–25.
22 Shaheen SO, Northstone K, Newson
RB, Emmett PM, Sherriff A, Henderson
AJ. Dietary patterns in pregnancy and
respiratory and atopic outcomes in
childhood. Thorax 2009; 64:411–7.
23 Bischoff-Ferrari HA, Giovannucci E,
Willett WC, Dietrich T, Dawson-Hughes
B. Estimation of optimal serum con-
centrations of 25-hydroxyvitamin D
for multiple health outcomes. Am J
Clin Nutr 2006; 84:18–28.
24 Henderson J, Granell R, Heron J et al.
Associations of wheezing phenotypes in
the first 6 years of life with atopy, lung
function and airway responsiveness in
mid-childhood. Thorax 2008; 63:974–80.
25 Royston P. Multiple imputation of
missing values: update of ice. Stata J
2005; 5:527–36.
26 Gallagher JC, Sai A, Templin T, Smith
L. Dose response to vitamin D supple-
mentation in postmenopausal women:
a randomized trial. Ann Intern Med
2012; 156:425–37.
27 Hollis BW, Johnson D, Hulsey TC,
Ebeling M, Wagner CL. Vitamin D sup-
plementation during pregnancy: dou-
ble-blind, randomized clinical trial of
safety and effectiveness. J Bone Miner
Res 2011; 26:2341–57.
28 Erkkola M, Kaila M, Nwaru BI et al.
Maternal vitamin D intake during preg-
nancy is inversely associated with asthma
and allergic rhinitis in 5-year-old chil-
dren. Clin Exp Allergy 2009; 39:875–82.
29 Shaheen SO, Jameson KA, Robinson
SM et al. Relationship of vitamin D
status to adult lung function and
COPD. Thorax 2011; 66:692–8.
30 Shaheen SO, Newson RB, Emmett P,
Sherriff A, Henderson J. Vitamin D
intake in pregnancy and respiratory and
atopic outcomes in childhood. Proceed-
ings from the European Respiratory
Society Annual Meeting. 2008. Avail-
able at http://www.ersnet.org/
31 Nguyen M, Trubert CL, Rizk-Rabin M,
Rehan VK, Besancon F, Cayre YE et al.
1,25-Dihydroxyvitamin D3 and fetal
lung maturation: immunogold detec-
tion of VDR expression in pneumo-
cytes type II cells and effect on
fructose 1,6 bisphosphatase. J Steroid
Biochem Mol Biol 2004; 89–90:93–7.
32 Cremers E, Thijs C, Penders J, Jansen
E, Mommers M. Maternal and child’s
vitamin D supplement use and vitamin
D level in relation to childhood lung
function: the KOALA Birth Cohort
Study. Thorax 2011; 66:474–80.
Supporting Information
Additional Supporting Information may be found in
the online version of this article:
Figure S1. Plot of trigonometric function to adjust
maternal vitamin D for season.
Figure S2. Illustrative plot showing the derivation of
the maternal 25(OH)D exposures.
Figure S3. Distribution of 25(OH)D in the mother.
Figure S4. Crude and adjusted odds ratios (OR) for
offspring atopic outcomes comparing across thresholds
of maternal 25(OH)D (< 50 nmol/L; 50–74.99 nmol/L
(reference class); ≥ 75 nmol/L).
Figure S5. Crude and adjusted mean difference in
pulmonary function outcomes (SD units) between
thresholds of maternal 25(OH)D (< 50 nmol/L; 50–
74.99 nmol/L (reference class); ≥ 75 nmol/L)
Figure S6. Crude and adjusted odds ratios (OR) for
offspring atopic outcomes comparing across thresholds
of maternal 25(OH)D (< 75 nmol/L (reference class);
≥ 75 nmol/L).
Figure S7. Crude and adjusted mean difference in pulmo-
nary function outcomes (SD units) across a threshold of
maternal 25(OH)D (< 75 nmol/L (reference), ≥ 75 nmol/L).
Figure S8. Crude and adjusted mean difference in pul-
monary function outcomes (SD units) between thresholds
of maternal 25(OH)D (< 27.5 nmol/L, 27.5–49.9 nmol/L;
50+ (reference class); ≥ 75 nmol/L).
Figure S9. Crude and adjusted associations between
maternal 25(OH)D (nmol/L) and longitudinal wheeze phe-
notypes.
Figure S10. Crude and adjusted associations between
maternal 25(OH)D (nmolL) and lung function at 15 y.
Figure S11. Complete case analysis.
Figure S12. Complete case analysis.
Table S1. Description of potential confounders and
mediators and models
Table S2. Unadjusted associations of maternal character-
istics with 25(OH)D in pregnancy. N = 5513a
Table S3. Coefficients for the results presented in Figures
2 and 3 of the main text. The coefficients (b) are odds
ratios compared to the reference quintile unless stated. See
supplementary Table S1 and methods in main text for a
description of models
Table S4. Estimated probability of wheeze at each age
by each latent class of wheeze.
© 2013 John Wiley & Sons Ltd, Clinical & Experimental Allergy, 43 : 1180–1188
1188 A. K Wills et al
